Low-dose low–molecular-weight heparin is anti-inflammatory during venous thrombosis
- 30 November 1998
- journal article
- Published by Elsevier BV in Journal of Vascular Surgery
- Vol. 28 (5), 848-854
- https://doi.org/10.1016/s0741-5214(98)70060-6
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosisJournal of Vascular Surgery, 1997
- Neutrophils Are the Initial Cell Type Identified in Deep Venous Thrombosis Induced Vein Wall InflammationASAIO Journal, 1996
- Venous Thrombosis–Associated Inflammation and Attenuation With Neutralizing Antibodies to Cytokines and Adhesion MoleculesArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein.JCI Insight, 1995
- A dual receptor system is required for basic fibroblast growth factor activityCell, 1991
- Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in RabbitsaAnnals of the New York Academy of Sciences, 1989
- Heparin, Its Fractions, Fragments and Derivatives Some Newer PerspectivesSeminars in Thrombosis and Hemostasis, 1985
- Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissuesJournal of Neuroscience Methods, 1983
- Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosisThrombosis Research, 1983
- Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238)Thrombosis Research, 1978